Skip to main content
SpringerLink
Log in

Postoperative Management of High-Risk Resectable Head and Neck Cancer

  • Chapter
  • First Online:
Head and Neck Cancer

  • 2384 Accesses

Abstract

Primary surgery is often a treatment modality used in the management of head and neck cancer. For patients with high-risk disease, surgery alone is insufficient, thus mandating a risk-adapted approach to determine which patients benefit most from the addition of adjuvant therapies. Typically, patients with advanced T stage, surgical margin involvement, perineural invasion, lymph node involvement, extracapsular spread, or bone involvement warrant the addition of postoperative radiotherapy. Randomized trials have also identified a select group of patients for whom the addition of chemotherapy concurrent with postoperative radiotherapy has been shown to improve outcomes. Specifically, patients with resected disease whose final pathology demonstrates the presence of extracapsular spread or surgical margin involvement should be treated with adjuvant, platinum-based chemoradiation. Targeted therapies in the adjuvant setting have achieved mixed success and remain under active investigation. The identification of more efficacious and less toxic adjuvant therapies is paramount to maximizing oncologic outcome and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maccomb WS, Fletcher GH. Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. Am J Roentgenol Radium Ther Nucl Med. 1957;77(3):397–414.

    CAS  PubMed  Google Scholar 

  2. Fletcher GH, Evers WT. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology. 1970;95(1):185–8.

    Article  CAS  PubMed  Google Scholar 

  3. Fletcher GH. Dose response curve of subclinical aggregates of epithelial cells and its practical application in the management of human cancers. In: Friedman M, editor. The biological and clinical basis of radiosensitivity. Springfield, IL: C.C. Thomas; 1974. p. 485–501.

    Google Scholar 

  4. Barkley Jr HT, Fletcher GH, Jesse RH, Lindberg RD. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg. 1972;124(4):462–7.

    Article  PubMed  Google Scholar 

  5. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev. 1975;2(3):177–91.

    Article  CAS  PubMed  Google Scholar 

  6. Marcus Jr RB, Million RR, Cassissi NJ. Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys. 1979;5(11-12):1943–9.

    Article  PubMed  Google Scholar 

  7. Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983;52(6):1008–13.

    Article  CAS  PubMed  Google Scholar 

  8. Kramer S, Gelber RD, Snow JB, Marcial VA, Lowry LD, Davis LW, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 1987;10(1):19–30.

    Article  CAS  PubMed  Google Scholar 

  9. Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, Jacobs JR, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys. 1991;20(1):21–8.

    Article  CAS  PubMed  Google Scholar 

  10. Farr HW, Goldfarb PM, Farr CM. Epidermoid carcinoma of the mouth and pharynx at memorial sloan-kettering cancer center, 1965 to 1969. Am J Surg. 1980;140(4):563–7.

    Article  CAS  PubMed  Google Scholar 

  11. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg. 1976;132(4):504–7.

    Article  CAS  PubMed  Google Scholar 

  12. Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978;1(2):107–11.

    Article  CAS  PubMed  Google Scholar 

  13. Carter RL, Tanner NSB, Clifford P, Shaw HJ. Perineural spread in squamous cell carcinomas of the head and neck: a clinicopathological study. Clin Otolaryngol Allied Sci. 1979;4(4):271–81.

    Article  CAS  PubMed  Google Scholar 

  14. Johnson JT, Barnes EL, Myers EN, Schramm Jr VL, Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 1981;107(12):725–9 (Chicago, IL: 1960).

    Article  CAS  PubMed  Google Scholar 

  15. Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26(1):3–11.

    Article  CAS  PubMed  Google Scholar 

  16. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–8.

    Article  CAS  PubMed  Google Scholar 

  17. Cooper JS, Pajak TF, Forastiere A, Jacobs J, Fu KK, Ang KK, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck. 1998;20(7):588–94.

    Article  CAS  PubMed  Google Scholar 

  18. Laramore GE, Scott CB, al-Sarraf M, Haselow RE, Ervin TJ, Wheeler R, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23(4):705–13.

    Article  CAS  PubMed  Google Scholar 

  19. Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24(2):115–26.

    Article  PubMed  Google Scholar 

  20. Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C. Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck. 2005;27(9):801–8.

    Article  PubMed  Google Scholar 

  21. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer. 2005;104(7):1408–17.

    Article  PubMed  Google Scholar 

  22. Jonkman A, Kaanders JH, Terhaard CH, Hoebers FJ, van den Ende PL, Wijers OB, et al. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(1):119–25.

    Article  PubMed  Google Scholar 

  23. Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, et al. ACR appropriateness criteria(R) adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol. 2011;47(7):554–9.

    Article  PubMed  Google Scholar 

  24. Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1990;61(5):779–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Jassem J, Bartelink H. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal. Cancer Treat Rev. 1995;21(5):447–62.

    Article  CAS  PubMed  Google Scholar 

  26. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338(25):1798–804.

    Article  CAS  PubMed  Google Scholar 

  27. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91(24):2081–6.

    Article  CAS  PubMed  Google Scholar 

  28. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88(4):876–83.

    Article  CAS  PubMed  Google Scholar 

  29. Wittes RE, Cvitkovic E, Shah J, Gerold FP, Strong EW. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep. 1977;61(3):359–66.

    CAS  PubMed  Google Scholar 

  30. Wittes R, Heller K, Randolph V, Howard J, Vallejo A, Farr H, et al. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep. 1979;63(9–10):1533–8.

    CAS  PubMed  Google Scholar 

  31. Morton RP, Rugman F, Dorman EB, Stoney PJ, Wilson JA, McCormick M, et al. Cisplatinum and Bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol. 1985;15(3):283–9.

    Article  CAS  PubMed  Google Scholar 

  32. A phase III randomised trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. Br J Cancer. 1990;61(2):311–5.

    Google Scholar 

  33. Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys. 1997;37(4):777–82.

    Article  CAS  PubMed  Google Scholar 

  34. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937–44.

    Article  PubMed  Google Scholar 

  35. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945–52.

    Article  CAS  PubMed  Google Scholar 

  36. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843–50.

    Article  PubMed  Google Scholar 

  37. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84(5):1198–205.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2007;8(7):613–24.

    Article  PubMed  Google Scholar 

  39. Bazley LA, Gullick WJ. The epidermal growth factor receptor family. Endocr Relat Cancer. 2005;12 Suppl 1:S17–27.

    Article  CAS  PubMed  Google Scholar 

  40. Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol. 2005;23(11):2445–59.

    Article  CAS  PubMed  Google Scholar 

  41. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol. 1993;11(10):1873–8.

    CAS  PubMed  Google Scholar 

  42. Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 1996;78(6):1284–92.

    Article  CAS  PubMed  Google Scholar 

  43. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, et al. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 1991;13(2):132–9.

    Article  CAS  PubMed  Google Scholar 

  44. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst. 1998;90(11):824–32.

    Article  CAS  PubMed  Google Scholar 

  45. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62(24):7350–6.

    CAS  PubMed  Google Scholar 

  46. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78.

    Article  CAS  PubMed  Google Scholar 

  47. Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, et al. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014;32(23):2486–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, et al. A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012;18(8):2336–43.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Harrington K, Berrier A, Robinson M, Remenar E, Housset M, de Mendoza FH, et al. Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. Eur J Cancer. 2013;49(7):1609–18.

    Article  CAS  PubMed  Google Scholar 

  50. Harrington KJ, Temam S, D’Cruz A, Jain MM, D'Onofrio I, Manikhas GM, et al., editors. Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN). ASCO Annual Meeting Proceedings; 2014.

    Google Scholar 

  51. Rosenthal DI, Harris J, Forastiere AA, Weber RS, Ridge JA, Myers JN, et al. Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. J Clin Oncol. 2009;27(28):4727–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Haffty BG, Son YH, Sasaki CT, Papac R, Fischer D, Rockwell S, et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys. 1993;27(2):241–50.

    Article  CAS  PubMed  Google Scholar 

  53. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36(5):999–1004.

    Article  CAS  PubMed  Google Scholar 

  54. Smid L, Budihna M, Zakotnik B, Soba E, Strojan P, Fajdiga I, et al. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2003;56(4):1055–62.

    Article  CAS  PubMed  Google Scholar 

  55. Racadot S, Mercier M, Dussart S, Dessard-Diana B, Bensadoun RJ, Martin M, et al. Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement. Radiother Oncol. 2008;87(2):164–72.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Hematology-Oncology, University of California, San Diego, Moores Cancer Center, 3855 Health Sciences Drive, #0658, La Jolla, CA, 92093-0658, USA

    Assuntina G. Sacco MD & Ezra E. Cohen MD

Authors
  1. Assuntina G. Sacco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ezra E. Cohen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ezra E. Cohen MD .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sacco, A.G., Cohen, E.E. (2016). Postoperative Management of High-Risk Resectable Head and Neck Cancer. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation